Petra Deegen

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer

Michael J. Giffin, Keegan S. Cooke, Edward K. Lobenhofer et al. · Clinical Cancer Research · 2020 · 238 citations · Full text

Medicine, Oncology, Pharmacology +15

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese et al. · Molecular Cancer Therapeutics · 2012 · 146 citations

Life Sciences, Immunology, Oncology +17

Highly Protective In Vivo Function of Cytomegalovirus IE1 Epitope-Specific Memory CD8 T Cells Purified by T-Cell Receptor-Based Cell Sorting

Marcus-Folker Pahl-Seibert, Markus Juelch, Jürgen Podlech et al. · Journal of Virology · 2005 · 106 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation

Christof K. Seckert, Angélique Renzaho, Hanna-Mari Tervo et al. · Journal of Virology · 2009 · 99 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer

Petra Deegen, Oliver S. Thomas, Olivier Nolan-Stevaux et al. · Clinical Cancer Research · 2021 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17